A Study to Assess the Effect of Safinamide on Levodopa Pharmacokinetics
NCT01026428
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Idiopathic Parkinson's Disease
Interventions
DRUG:
Safinamide + Levodopa
OTHER:
Placebo + Levodopa
Sponsor
Newron Pharmaceuticals SPA